Clinical trials
Phase 3 Obesity trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 7 |
| 2025 | 2 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 11 |
| Active, not recruiting | 5 |
| Not yet recruiting | 3 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 15 |
| Eli Lilly and Company | 14 |
| AstraZeneca | 2 |
| Boehringer Ingelheim | 1 |
| Hoffmann-La Roche | 1 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 35 |
| Overweight | 25 |
| Diabetes Mellitus, Type 2 | 8 |
| Nutrition Disorders | 5 |
| Sleep Apnea, Obstructive | 5 |
| Cardiovascular Diseases | 2 |
| Breast Neoplasms | 1 |
| Heart Failure | 1 |
| Hypertension | 1 |
| Myocardial Infarction | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.